Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07528690 · ClinicalTrials.gov registry record · Phase 2
Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)
A Phase 2 study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
NCT07528690: Clinical Trial Phase 2 study, sponsored by VA Office of Research and Development.
NCT07528690 is a Phase 2 study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 162 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07528690, a Phase 2 study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to find out whether changing the microbes in the bowels of Veterans with cirrhosis and hepatic encephalopathy (a condition that affects the brain as a result of liver problems) using capsules made from microbes from healthy people can prevent future episodes of hepatic encephalopathy.
Interventions
- OTHER Placebo capsule
- BIOLOGICAL Microbiota transplant therapy (MTT) capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2026-10-30 |
| Est. Completion | 2031-03-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07528690
The ClinicalTrials.gov registry entry for NCT07528690 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo capsule is the first listed.
NCT07528690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07528690 about?
NCT07528690 is a clinical study titled "Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)". The goal of this clinical trial is to find out whether changing the microbes in the bowels of Veterans with cirrhosis and hepatic encephalopathy (a condition that affects the brain as a result of liver problems) using capsules made from microbes from healthy people can prevent future episodes of hep...
What is the current status of trial NCT07528690?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2026-10-30. Estimated completion is 2031-03-03.
What interventions are being tested in trial NCT07528690?
The interventions under investigation include: Placebo capsule (OTHER), Microbiota transplant therapy (MTT) capsules (BIOLOGICAL).
Who is sponsoring clinical trial NCT07528690?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.